AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 556.7M
Enterprise Value 341.85M
Trailing P/E 7.27
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.66

Trading Information

Stock Price History

Beta (3Y Monthly) 1.32
52-Week Change 3-83.27%
S&P500 52-Week Change 36.00%
52 Week High 33.2000
52 Week Low 30.3500
50-Day Moving Average 30.4789
200-Day Moving Average 30.5366

Share Statistics

Avg Vol (3 month) 31.19M
Avg Vol (10 day) 3616.66k
Shares Outstanding 5106.72M
Float 85.07M
% Held by Insiders 110.71%
% Held by Institutions 122.68%
Shares Short (Jun 28, 2019) 419.71M
Short Ratio (Jun 28, 2019) 48.82
Short % of Float (Jun 28, 2019) 421.81%
Short % of Shares Outstanding (Jun 28, 2019) 413.91%
Shares Short (prior month May 31, 2019) 422.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/1
Last Split Date 3Aug 1, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-47.17%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.98M
Net Income Avi to Common (ttm)6.14M
Diluted EPS (ttm)0.0550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.16M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)1.65M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.68
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-10.97M
Levered Free Cash Flow (ttm)-7.48M